Search

Calmare NJ USA

Tag

drug free chronic pain therapy

My position on Ketamine for the treatment of CRPS and RSD

By Dr. Michael Cooney, Clinical Director, Calmare Therapy NJ

KetamineOver the past few years, a significant percentage of the RSD / CRPS /fibromyalgia patients I treated had previously undergone Ketamine Infusion Therapy.  I’d like to offer a little background on Ketamine and share some feedback from my patients who used it in various forms—through IV, creams and even as a form of coma-inducing sedation.

For RSD, CRPS and fibromyalgia sufferers, Ketamine is sometimes recommended for temporary chronic pain relief. It is an NMDA blocker that shuts down pain signals coming from the brain and then reboots the brain without the pain signal.

Successful outcome statistics for RSD patients treated with Ketamine are less than 50%. Boosters are necessary every two – three months and the cost averages about $2,000/ treatment. Each IV infusion takes about four to five hours.

Patients sometimes experience significant and unpleasant side effects from this drug, including hallucinations, nausea, extreme fatigue, mental confusion, substantial weight-gain and ‘claw hand’ syndrome.

Criteria to undergo Calmare scrambler therapy after Ketamine treatment

If you have undergone Ketamine treatment without a successful outcome, you can undergo Calmare (assuming your medical condition is determined appropriate for treatment). However, there must be a full two-month span between the last Ketamine treatment and the start of Calmare.

In fact, the less neurolytic drugs (Lyrica, Neurontin, Cymbalta) patients are using during Calmare Therapy, the better. Why? Because these drugs have an effect on brain activity and conflict with the functionality of Calmare to optimally do its job.

In other words, you need to feel your body’s untreated pain in order to identify when the scrambler therapy is lessening the neuropathy, for how long and to what degree.

I realize that for patients who have been reliant on neurolytic drugs for months or years, reducing the dosage of medication before our treatment starts can be daunting. My argument is that the potential rewards for patients who undergo Calmare Therapy may eliminate the need for these expensive and debilitating drugs.  Permanently.

Therefore, I believe this is a gamble worth pursuing.

Every patient’s case is unique because we all react to injury and pain, acute or chronic, in different ways. If you or a loved one is interested in learning more about Calmare Therapy, please feel free to contact me directly at (201) 933-444-zero.

New Report: Chronic pain costs the US $558 billion a year

The Institute of Medicine reported on Wednesday that chronic pain affects an estimated 116 million American adults—more than the total affected by heart disease, cancer, and diabetes combined. Their latest findings report that our nation has a “moral imperative” to find viable solutions to help people living with chronic pain.

I’d like to share this article published by The Associated Press (AP) yesterday, which offers an overview  the Institute’s in-depth report. For those of us at Rutherford Allied Medical Group, this report serves as important encouragement and inspiration in our chronic pain therapy solution offering Calmare Pain Therapy: 

Treating pain better should be a priority, report says

Thursday, June 30, 2011

BY LAURAN NEERGAARD – THE ASSOCIATED PRESS

WASHINGTON — Nearly a third of Americans experience long-lasting pain — the kind that lingers for weeks to months — and too often feel stigma rather than relief from a health care system poorly prepared to treat them, the Institute of Medicine said Wednesday.

Chronic pain is costing the nation at least $558 billion a year in medical bills, sick days and lost productivity, the report found. That’s more than the cost of heart disease, the No. 1 killer.

All kinds of ailments can trigger lingering pain, from arthritis to cancer, spine problems to digestive disorders, injuries to surgery. Sometimes, chronic pain can be a disease all its own, the report stressed.

Pain management is “a moral imperative,” the report concludes, urging the government, medical groups and insurers to take a series of steps to transform the field.

“We’re viewing this as a critical issue for the United  States,” said Dr. Philip Pizzo,  dean of medicine, who headed the months-long probe.

Blog at WordPress.com.

Up ↑

%d bloggers like this: